Cite
Dent S, Verma Sh, Latreille J, et al. The role of HER2-targeted therapies in women with HER2-overexpressing metastatic breast cancer. Curr Oncol. 2009;16(4):25-35doi: 10.3747/co.v16i4.469.
Dent, S., Verma, S. h., Latreille, J., Rayson, D., Clemons, M., Mackey, J., Verma, S., Lemieux, J., Provencher, L., Chia, S., Wang, B., & Pritchard, K. (2009). The role of HER2-targeted therapies in women with HER2-overexpressing metastatic breast cancer. Current oncology (Toronto, Ont.), 16(4), 25-35. https://doi.org/10.3747/co.v16i4.469
Dent, S, et al. "The role of HER2-targeted therapies in women with HER2-overexpressing metastatic breast cancer." Current oncology (Toronto, Ont.) vol. 16,4 (2009): 25-35. doi: https://doi.org/10.3747/co.v16i4.469
Dent S, Verma Sh, Latreille J, Rayson D, Clemons M, Mackey J, Verma S, Lemieux J, Provencher L, Chia S, Wang B, Pritchard K. The role of HER2-targeted therapies in women with HER2-overexpressing metastatic breast cancer. Curr Oncol. 2009 Aug;16(4):25-35. doi: 10.3747/co.v16i4.469. PMID: 19672422; PMCID: PMC2722050.
Copy
Download .nbib